FDA approves Awiqli, first once-weekly insulin for pediatric patients with type 2 diabetes
NVO•The FDA approved Awiqli as the first once-weekly insulin for pediatric patients with type 2 diabetes. It is administered by subcutaneous injection once weekly.
1. FDA approval
The FDA approved Awiqli as the first once-weekly insulin for pediatric patients with type 2 diabetes mellitus. Awiqli is administered by injection under the skin once a week.
